Patent ID: 9605317
Date: 2017-03-28
CPC Classifications: A61P,C12Q

Claim:
1. A method of treating a patient with cancer, the method comprising: a. performing an assay on the patient's DNA to determine the presence or absence of a biomarker; wherein said biomarker is selected from the group consisting of a homozygous genotype of the minor allele, G, of rs4553808, a homozygous genotype of the minor allele, G, of rs1474642, a homozygous genotype of the minor allele, G, of rs12568757, a homozygous genotype of the minor allele, A, of rs11974610, 1 or 2 copies of the minor allele, G, of rs916758 and 1 or 2 copies of the minor allele, T, of rs1261134; and, b. administering bortezomib to the patient lacking said biomarker.